Skip to main content
. 2024 Dec 25;17(1):26. doi: 10.3390/cancers17010026

Table 3.

Gene targets and key cellular processes modulated by miRNAs involved in cancer.

miRNAs Target Genes Cellular Processe
miR-34a UHRF2 Proliferation, regulation of DNA methylation, genomic stability, and response to DNA damage.
MDM4 Regulates TP53, inhibits cell cycle arrest and apoptosis mediated by p53/TP53 and TP73/p73, and inhibits the degradation of MDM2.
MET Growth, survival, cell migration, invasion, cancer progression, and malignancy.
miR-145 SOX 11 Regulates cell proliferation, differentiation, and migration.
ERG Proliferation, differentiation, and apoptosis.
MYO6 Cell migration and invasion.
GMFB Proliferation, migration, inflammation, and apoptosis.
BCR Cell signaling, proliferation, differentiation, survival, migration, invasion, and apoptosis.
miR-221 FOXS1 Proliferation, migration, invasion, and resistance to apoptosis.
KIT Cell survival and proliferation.
DMTF1 Senescence, apoptosis, cell cycle regulation, and DNA damage response.
SORCS1 Cell proliferation, migration and invasion, and resistance to apoptosis.
CCND1 Cell cycle during the G1/S transition, proliferation, evasion of apoptosis, therapy resistance, and invasion.
miR-21 STAT3 Proliferation, invasion, metastasis, angiogenesis, evasion of apoptosis, and therapy resistance.
SKP2 Cell cycle progression through negative regulation of p27, resistance to apoptosis, invasion, and migration.
CREBRF Proliferation, survival, and resistance to apoptosis.
MALT1 Proliferation, survival, resistance to apoptosis, and inflammatory response.
miR-106a TP53 Apoptosis, cell cycle regulation, DNA damage response, oxidative stress control, inhibition of invasion and metastasis.
RB1 Cell cycle, proliferation, senescence, apoptosis, maintenance of genomic stability, invasion, and metastasis.
E2F1 Cellular proliferation, cell cycle regulation, apoptosis, differentiation, DNA damage response, invasion, and metastasis.
BCL2L11 (Bim) Apoptosis, cell cycle, cellular stress response and sensitivity to therapies.